ERC Overview
- Year Founded
-
2008
- Status
-
Private
- Latest Deal Type
-
University Spin-Out
ERC General Information
Description
Operator of a biopharmaceutical company intended to focus on treating patients with glioblastoma multiforme. The company has developed cell-based immunotherapy that eliminates cancer cells for the treatment of patients suffering from brain cancers and offers a range of products and services including clinical trials, right-to-try options, and product manufacturing.
Contact Information
Website
www.erc-immunotherapy.comCorporate Office
- Scientific Park Crealys
- Rue Jean Sonet 10, Isnes
- 5032 Gembloux
- Belgium
Corporate Office
- Scientific Park Crealys
- Rue Jean Sonet 10, Isnes
- 5032 Gembloux
- Belgium
ERC Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. University Spin-Out | 01-Jan-2008 | Completed | Startup |
ERC Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ERC Executive Team (1)
| Name | Title | Board Seat |
|---|---|---|
| Apostolos Stathopoulos Ph.D | Co-Founder and Chief Executive Officer |
ERC FAQs
-
When was ERC founded?
ERC was founded in 2008.
-
Who is the founder of ERC?
Apostolos Stathopoulos Ph.D is the founder of ERC.
-
Who is the CEO of ERC?
Apostolos Stathopoulos Ph.D is the CEO of ERC.
-
Where is ERC headquartered?
ERC is headquartered in Gembloux, Belgium.
-
What industry is ERC in?
ERC’s primary industry is Biotechnology.
-
Is ERC a private or public company?
ERC is a Private company.
-
What is ERC’s current revenue?
The current revenue for ERC is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
